Piramal Pharma Ltd
About
Piramal Pharma Limited (PPL) is a leading pharmaceutical company and part of the Piramal Group. The company was established on March 4, 2020. PPL is headquartered in Mumbai, Maharashtra, and is led by Peter DeYoung, Executive Director and CEO of Piramal Global Pharma.PPL operates across a wide range of pharmaceutical and healthcare segments, including chemical and medicinal products. It has a strong global presence, with end-to-end manufacturing capabilities across 15 facilities and a distribution network spanning over 100 countries. The company’s key business divisions include Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization (CDMO); Piramal Critical Care (PCC), which focuses on complex hospital generics; and the India Consumer Healthcare division, which offers over-the-counter products.
Featured In Fortune India Ranking
Financial Data 2024
Fortune India Coverage
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue (INR Cr) | 8605 18.0% | 7292 6.6% | 6839 3.7% | 6597 - |
| Net Operating Income (INR Cr) | 8171 15.39% | 7082 7.97% | 6559 3.87% | 6315 0.00% |
| Profit (INR Cr) | 18 - | -186 - | 376 -55.0% | 835 - |
| Assets (INR Cr) | 12822 1.7% | 12612 14.7% | 10991 25.2% | 8780 - |
| Net Worth (INR Cr) | 7911 16.8% | 6774 1.2% | 6697 19.5% | 5605 0.0% |
| Employee Cost (INR Cr) | 2030 7.0% | 1896 19.4% | 1589 8.3% | 1468 - |
| Interest Cost (INR Cr) | 448 | 344 | 198 | 163 |
| Cash & Bank Balance (INR Cr) | 483 | 308 | 329 | 406 |
| Total Debt (INR Cr) | 4710 | 5637 | 4128 | 3025 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Profit As % Of Revenues | 0.2% | - | 5.5% | 12.7% |
| Profit As % Of Assets | 0.1% | - | 3.4% | 9.5% |
| Profit As % Of Networth | 0.2% | - | 5.6% | 14.9% |
| Interest Cost to EBITDA % | 39.6% | 55.4% | 43.1% | 11.5% |
| Debt to Equity Ratio | 0.60 | 0.83 | 0.62 | 0.54 |
| RONW | 0.2% | - | 6.1% | 14.9% |
| ROCE | 5.4% | 1.9% | 6.9% | 12.7% |